Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease

Annals of Hepatology

Volumn 12, Issue 2, 2013, Pages 236-247

  Diaz Sanchez, Antonio ^a   Matilla, Ana ^b   Nuñez, Oscar ^c   Rincon, Diego ^b   Lorente, Raquel ^b   Lo Iacono, Oreste ^d   Merino, Beatriz ^b   Hernando, Ana ^b   Campos, Rocio ^a   Clemente, Gerardo ^b   Bañares, Rafael ^b  

^a Hospital Universitario del Sureste de Madrid   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^d Aranjuez   (Spain)

Author keywords

Cirrhosis; Hyaluronic Acid; Vascular cell adhesion molecule 1

Indexed keywords

ADEFOVIR; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOXORUBICIN; HYALURONIC ACID; IODINATED POPPYSEED OIL; LAMIVUDINE; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CHRONIC LIVER DISEASE; CLASSIFICATION ALGORITHM; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY GRADIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTRODE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HEPATIC VENOUS PRESSURE GRADIENT; HEPATITIS B; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER VEIN; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; NONHUMAN; PERIPHERAL VEIN; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION; SCORING SYSTEM; SPLANCHNIC HEMODYNAMICS; THROMBOCYTE COUNT; TREATMENT RESPONSE; TUMOR VOLUME; VASCULITIS; BLOOD; CHI SQUARE DISTRIBUTION; LIVER TUMOR; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPLANCHNIC BLOOD FLOW; STATISTICAL MODEL; TUMOR INVASION; VENOUS PRESSURE;

AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATIC VEINS; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPLANCHNIC CIRCULATION; TUMOR MARKERS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1; VENOUS PRESSURE;

EID: 84885629953     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31362-6     Document Type: Article

References (35)

1. Pigott R, Dillon LP, Hemingway IH, Gearing AJ. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are presented in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187: 584-9.
2. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-11.
3. Byrne GJ, Ghellal A, Iddon J, Blann AD, Venizelos V, Kumar S, Howell A, et al. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst 2000; 92: 1329-36.
4. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995; 376: 517-9.
5. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, Rosenberg T, et al. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, vascular adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 2003; 98: 478-85.
6. Nakata B, Hori T, Sunami T, Ogawa Y, Yashiro M, Maeda K, Sawada T, et al. Clinical significance of serum soluble intercellular adhesion molecule 1 in gastric cancer. Clin Cancer Res 2000; 6: 1175-9.
7. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Kremmyda A, Bramis I, Tsigris C. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlation with clinicopathological features, patient survival and tumor surgery. Eur J Cancer 2001; 37; 2392-7.
8. Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, Granger DN. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation 2001; 8: 335-45.
9. Chistiansen I, Sundström C, Tötterman TH. Elevated serum levels of soluble cell adhesion molecule-1 (sVCAM-1) closely reflects tumour burden in chronic B-lymphocytic leukaemia. Br J Hematol 1998; 103: 1129-37.
10. O'Hanlon DM, Fitzsimons H, Lynch J, Tormey S, Malone C, Given HF. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer 2002; 38: 2252-7.
11. Pirisi M, Fabris C, Falleti E, Soardo G, Toniutto P, Vitulli D, Gonano F, et al. Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases. Dis Markers 1996; 13: 11-7.
12. Lo Iacono O, Garcia-Monzon C, Almasio P, García-Buey L, Craxí A, Moreno-Otero R. Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha. Aliment Pharmacol Ther 1998; 12: 1091-9.
13. Giron-Gonzalez JA, Martinez-Sierra C, Rodriguez-Ramos C, Rendón P, Macías MA, Fernández-Gutiérrez C, Díaz F, et al. Adhesion molecules as a prognostic marker of liver cirrhosis. Scand J Gastroenterol 2005; 40: 217-24.
14. Lo Iacono O, Rincon D, Hernando A, Ripoll C, Catalina MV, Salcedo M, Clemente G, et al. Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis. Liver Int 2008; 28: 1129-35.
15. Ho JW, Poon RT, Tong CS, Fan ST. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2014-8.
16. Hyodo I, Jinno K, Tanimizu M, Doi T, Nishikawa Y, Hosokawa Y, Moriwaki S. Intercellular adhesion molecule-1 release from human hepatocellular carcinoma. Cancer Detect Prev 1996; 20: 308-15.
17. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-70.
18. Child CG, Turcotte JC. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
19. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.
20. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
21. Lencioni R, Llovet JM. Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma. Semin Liver Dis 2010; 30: 52-60.
22. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient anything worth doing should be done right. Hepatology 2004; 39: 280-2.
23. Adams DH, Burra P, Hubscher SG, Elias E, Newman W. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 1994; 19: 588-94.
24. Lim AG, Jazrawi RP, Levy JH, Petroni ML, Douds AC, Maxwell JD, Northfield TC. Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol 1995; 22: 416-22.
25. Yamaguchi N, Tokushige K, Haruta I, Yamahuchi K, Hayashi N. Analysis of adhesion molecules in patients with idiopathic portal hypertension. J Gastroenterol Hepatol 1999; 14: 364-9.
26. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000; 15: 945-51.
27. Fontanini G, Vignati S, Boldrini L, Chinè S, Silvestri V, Lucchi M, Mussi A, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997; 3: 861-5.
28. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996; 56: 2013-6.
29. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brains tumors. Cancer Res 1995; 55: 1189-93.
30. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53: 4727-35.
31. Park YN, Kim YB, Yang KM, Park C. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 2000; 124: 1061-5.
32. Iavarone M, Lampertico P, Iannuzzi F, Manenti E, Donato MF, Arosio E, Bertolini F, et al. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. J Viral Hepat 2007; 14: 133-9.
33. Poon RTP, Lau CPY, Cheung ST, Yu WC, Fan ST. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res 2003; 63: 3121-6.
34. Spahr L, Becker C, Pugin J, Majno PE, Hadengue A. Acute portal hemodynamics and cytokine changes following selective transarterial chemoembolization in patients with cirrhosis and hepatocellular carcinoma. Med Sci Monit 2003; 9: 383-8.
35. Shimada MJ, Kajiyama K, Hasegawa H, Gion T, Ikeda Y, Shirabe K, Takenaka K, et al. Role of adhesion molecule expression and soluble fractions in hepatic resection. Am Coll Surg 1998; 186: 534-41.